logo

Judge orders RFK Jr.'s health department to stop sharing Medicaid data with deportation officials

Independent10 hours ago
A federal judge ordered the nation's health department to stop giving deportation officials access to the personal information — including home addresses — of all 79 million Medicaid enrollees.
The U.S. Department of Health and Human Services first handed over the personal data on millions of Medicaid enrollees in a handful of states in June. After an Associated Press report identified the new policy, 20 states filed a lawsuit to stop its implementation.
In July, the Centers for Medicare and Medicaid Services entered into a new agreement that gave the Department of Homeland Security daily access to view the personal data — including Social Security numbers and home address — of all the nation's 79 million Medicaid enrollees. Neither agreement was announced publicly.
The extraordinary disclosure of such personal health data to deportation officials in the Trump administration's far-reaching immigration crackdown immediately prompted the lawsuit over privacy concerns.
The Medicaid data sharing is part of a broader effort by the Trump administration to provide DHS with more data on migrants. In May, for example, a federal judge refused to block the Internal Revenue Service from sharing immigrants' tax data with Immigration and Customs Enforcement to help agents locate and detain people living without legal status in the U.S.
The order, issued by federal Judge Vince Chhabria in California, temporarily halts the health department from sharing personal data of enrollees in those 20 states, which include California, Arizona, Washington and New York.
'Using CMS data for immigration enforcement threatens to significantly disrupt the operation of Medicaid—a program that Congress has deemed critical for the provision of health coverage to the nation's most vulnerable residents,' Chhabria wrote in his decision, issued on Tuesday.
Chhabria, an appointee of President Barack Obama, said that the order will remain in effect until the health department outlines 'reasoned decisionmaking' for its new policy of sharing data with deportation officials.
A spokesperson for the federal health department declined to directly answer whether the agency would stop sharing its data with DHS. HHS has maintained that its agreement with DHS is legal.
Immigrants who are not living in the U.S. legally, as well as some lawfully present immigrants, are not allowed to enroll in the Medicaid program that provides nearly free coverage for health services. But federal law requires all states to offer emergency Medicaid, a temporary coverage that pays only for lifesaving services in emergency rooms to anyone, including non-U.S. citizens. Medicaid is a jointly funded program between states and the federal government.
Immigration advocates have said the disclosure of personal data could cause alarm among people seeking emergency medical help for themselves or their children. Other efforts to crack down on illegal immigration have made schools, churches, courthouses and other everyday places feel perilous to immigrants and even U.S. citizens who fear getting caught up in a raid.
'Protecting people's private health information is vitally important,' Washington state's Attorney General Nick Brown said in a statement. 'And everyone should be able to seek medical care without fear of what the federal government may do with that information.'
___
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘Demon' rabbits growing hornlike warts in Colorado are no danger, scientists say
‘Demon' rabbits growing hornlike warts in Colorado are no danger, scientists say

The Guardian

time34 minutes ago

  • The Guardian

‘Demon' rabbits growing hornlike warts in Colorado are no danger, scientists say

A group of rabbits in Colorado with grotesque, hornlike growths may seem straight out of a low-budget horror film, but scientists say there is no reason to be spooked – the furry creatures merely have a relatively common virus. The cottontails recently spotted in Fort Collins are infected with the mostly harmless Shope papillomavirus, which causes wart-like growths that protrude from their faces like metastasizing horns. Viral photos have inspired a fluffle of unflattering nicknames, including 'Frankenstein bunnies', 'demon rabbits' and 'zombie rabbits'. But their affliction is nothing new, with the virus inspiring ancient folklore and fueling scientific research nearly 100 years ago. The virus probably influenced the centuries-old jackalope myth in North America, which told of a rabbit with antlers or horns, among other animal variations. The disease in rabbits also contributed to scientists' knowledge about the connection between viruses and cancer, such as the human papillomavirus that causes cervical cancer. The virus in rabbits was named after Dr Richard E Shope, a professor at the Rockefeller University who discovered the disease in cottontails in the 1930s. News about the rabbit sightings in Fort Collins, 65 miles (105km) north of Denver, started getting attention after residents started spotting them around town and posting pictures. Kara Van Hoose, a spokesperson for Colorado parks and wildlife, told the Associated Press on Wednesday that the agency had been getting calls about the rabbits seen in Fort Collins. But she said that it was not uncommon to see infected rabbits, especially in the summer, when the fleas and ticks that spread the virus are most active. The virus can spread from rabbit to rabbit but not to other species, including humans and pets, she said. The growths resemble warts but can look like horns if they grow longer, Van Hoose said. The growths do not harm rabbits unless they grow on their eyes or mouths and interfere with eating. Rabbits' immune systems are able to fight the virus and, once they do, the growths disappear, she said.

Scientists use AI to create new antibiotics that can kill deadly drug-resistant superbugs
Scientists use AI to create new antibiotics that can kill deadly drug-resistant superbugs

The Independent

timean hour ago

  • The Independent

Scientists use AI to create new antibiotics that can kill deadly drug-resistant superbugs

Researchers have developed antibiotics that can potentially kill drug-resistant gonorrhoea and MRSA with the help of artificial intelligence. The team at the Massachusetts Institute of Technology (MIT) used generative AI algorithms to design more than 36 million molecular compounds, identifying two new drugs that were then tested in lab settings and in mice. According to their study, published in Cell on Thursday, the AI scanned through a list of potential molecules and predicted which ones could work as antibiotics, while also avoiding structures that could be harmful to humans or too similar to existing drugs. Both new antibiotics were able to kill strains of bacteria that are becoming increasingly difficult to treat with existing antibiotics. One of the new drugs, called NG1, was designed to specifically target gonorrhoea, a sexually transmitted infection that has been rapidly developing resistance to antibiotics. The World Health Organisation has warned that gonorrhoea is becoming untreatable in some cases due to antibiotic resistance. New data from the UK Health Security Agency (UKHSA) reveals a concerning increase in resistant cases. Between January 2024 and March 2025, 17 cases of ceftriaxone-resistant gonorrhoea were reported, 13 in 2024 and four in the first three months of 2025. The second drug, named DN1, was effective against methicillin-resistant staphylococcus aureus (MRSA), a type of staph infection that no longer responds to many commonly used antibiotics. MRSA often begins as a painful, pus‑filled skin boil and can spread to cause serious, hard‑to‑treat infections in the bloodstream, lungs or bones, especially in people with weakened immune systems. After tests, it was found that NG1 and DN1 stood out for their ability to kill dangerous bacteria in both test tubes and mice. In animal studies, the drugs were able to successfully treat skin infections caused by MRSA and clear gonorrhoea infections. The team also hopes to use their AI platform to design new drugs for other superbugs in the future, including those that cause tuberculosis and hospital-acquired infections like Pseudomonas aeruginosa. 'We're excited about the new possibilities that this project opens up for antibiotics development,' said James Collins, senior author of the study and Termeer Professor of Medical Engineering and Science in MIT's Institute for Medical Engineering and Science (IMES) and Department of Biological Engineering. 'Our work shows the power of AI from a drug design standpoint, and enables us to exploit much larger chemical spaces that were previously inaccessible.' What makes this discovery significant is that both drugs work in new ways. Many antibiotics rely on similar mechanisms to kill bacteria, which has allowed some bacteria to evolve resistance over time. These new compounds appear to attack bacterial membranes in ways not used by current medicines, giving scientists hope that they could be harder for bacteria to resist. 'We wanted to get rid of anything that would look like an existing antibiotic, to help address the antimicrobial resistance crisis in a fundamentally different way,' said Aarti Krishnan, lead author and MIT postdoc. Although the findings are promising, the researchers have stressed that these new antibiotics are still in early development. They must go through years of testing to prove they are safe and effective in humans. The next steps include refining the chemical structure of the drugs, testing for potential side effects, and eventually conducting clinical trials. Antimicrobial resistance, or when bacteria evolve to resist the drugs used to kill them, is a growing public health crisis. It is estimated to be responsible for more than one million deaths globally each year, with experts warning that without urgent action, even minor infections could once again become deadly. In the UK, there were 66,730 serious antibiotic-resistant infections recorded in 2023 alone, according to a report by The Times.

I ignored my itchy legs and common sleep complaint. Then doctors found something horrifying on a scan. I'd left it far too late
I ignored my itchy legs and common sleep complaint. Then doctors found something horrifying on a scan. I'd left it far too late

Daily Mail​

timean hour ago

  • Daily Mail​

I ignored my itchy legs and common sleep complaint. Then doctors found something horrifying on a scan. I'd left it far too late

Sweating in his sleep, itchy ankles, a persistent cough and losing weight by the day - when Mike Yewdell was hit by these persistent symptoms in 2017, he was baffled. For about four months, Yewdell, then 27, thought he was suffering from a harmless dry cough. It caused his chest to make a cracking sound when he stretched and left him in pools of sweat in the middle of the night. Your browser does not support iframes.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store